Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00502827 · ClinicalTrials.gov registry record · NA
Smoking Cessation for HIV/AIDS Patients
A NA study of Human Immunodeficiency Virus, sponsored by M.D. Anderson Cancer Center.
- Completed
- Registry status
- NA
- Development phase
- 706
- Enrollment target
- 2
- Study locations
NCT00502827: Completed NA study of Human Immunodeficiency Virus, sponsored by M.D. Anderson Cancer Center.
NCT00502827 is a NA study of Human Immunodeficiency Virus that has completed, run by M.D. Anderson Cancer Center. The registered enrollment target is 706 participants, above the 166-participant average among 39 other Human Immunodeficiency Virus trials with a reported enrollment target (325% higher). The trial reports 2 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00502827, a NA study of Human Immunodeficiency Virus, has completed, sponsored by M.D. Anderson Cancer Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 706 participants
- Enrollment target
- 2
- Study locations
Study Summary
The goal of this research study is to look at treatments that may help individuals who have HIV/AIDS to stop smoking.
Conditions Studied
Interventions
- BEHAVIORAL Cell Phone Intervention
- OTHER Recommended Standard of Care
Study Locations (2)
Texas
- Thomas Street Clinic - Houston
- University of Texas MD Anderson Cancer Center - Houston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 706 participants |
| Start Date | 2004-01 |
| Est. Completion | 2015-04 |
| Phase | NA |
What the finished NCT00502827 record still lists
NCT00502827 is an interventional study that assigns participants to a tested intervention. The registered 706 participants enrollment target is mid-sized for trials with a published cap, above the 166-participant average among 39 other Human Immunodeficiency Virus trials with a reported enrollment target (325% higher).
The record links to 1 condition, with Human Immunodeficiency Virus appearing as the primary indexed condition, and to 2 interventions - of which Cell Phone Intervention is the first listed.
NCT00502827 reports a single indexed study location in Texas.
Frequently Asked Questions
What is clinical trial NCT00502827 about?
NCT00502827 is a clinical study titled "Smoking Cessation for HIV/AIDS Patients". The goal of this research study is to look at treatments that may help individuals who have HIV/AIDS to stop smoking.
What is the current status of trial NCT00502827?
This trial is currently completed. It is a NA study. The enrollment target is 706 participants. The study started on 2004-01. Estimated completion is 2015-04.
What conditions does trial NCT00502827 study?
This clinical trial studies the following conditions: Human Immunodeficiency Virus.
What interventions are being tested in trial NCT00502827?
The interventions under investigation include: Cell Phone Intervention (BEHAVIORAL), Recommended Standard of Care (OTHER).
Who is sponsoring clinical trial NCT00502827?
This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00502827 being conducted?
This trial has 2 study locations across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Human Immunodeficiency Virus
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00502827's enrollment target sits among peer trials
706 4th of 39 higher than 36 of 39 other Human Immunodeficiency Virus trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Human Immunodeficiency Virus trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Text Education About Cardiovascular Health and HIV (TEACH-HIV)
RECRUITING · NA
-
Gut Microbiota-Mediated Inflammatory Interactions Between AUD and HIV Infection
RECRUITING · NA
-
Increasing PrEP Use in High-Risk Social Networks of African-American MSM in Underserved Low-Risk Cities
ACTIVE NOT RECRUITING · NA
-
Integration of Hypertension Management Into HIV Care in Nigeria
ACTIVE NOT RECRUITING · NA
-
Cross-disciplinary HIV Integrated Mental Health Support Intervention
ACTIVE NOT RECRUITING · NA
-
Improving Drug Adherence Among Adolescents in Uganda Using SMS Reminders
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06480383 · 705 participants · Phase 2
Study of ITI-1284 as an Adjunctive Treatment in Patients With Generalized Anxiety Disorder
- NCT07067463 · 705 participants · Phase 3
A Study of Orelabrutinib in Patients With Primary Progressive Multiple Sclerosis
- NCT05796687 · 704 participants · NA
Evaluation of My Future Self, an New Teen Pregnancy Prevention Group Intervention for Youth in Non-traditional Settings
- NCT06350734 · 704 participants
Quality of Life After Treatment for Bladder Cancer: The Bladder Cancer Survivorship Study
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia